By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Award-Winning Film An Inconvenient Study Sparks Global Debate on Vaccine Safety and Chronic Disease
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Health > Award-Winning Film An Inconvenient Study Sparks Global Debate on Vaccine Safety and Chronic Disease
Award-Winning Film An Inconvenient Study Sparks Global Debate on Vaccine Safety and Chronic Disease
Health

Award-Winning Film An Inconvenient Study Sparks Global Debate on Vaccine Safety and Chronic Disease

GlobeNews Wire
Last updated: 24/10/2025 12:38 AM
GlobeNews Wire
Published: 24/10/2025
Share
SHARE

AUSTIN, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) — The award-winning film An Inconvenient Study has been seen by millions following its global premiere on October 12th, sparking international discussion and debate about vaccine safety, scientific transparency, and the alarming rise in chronic illness among America’s children.

Produced by the Informed Consent Action Network (ICAN) and Emmy Award–winning journalist Del Bigtree, the film investigates an unpublished vaccinated-versus-unvaccinated study conducted within the prestigious Henry Ford Health System.

In 2016, Bigtree challenged Dr. Marcus Zervos, head of infectious disease at Henry Ford, to conduct a rigorous comparison of vaccinated and unvaccinated children and to publish the results regardless of outcome. Dr. Zervos accepted, conducted the study, and later declined to submit it for publication. On hidden camera, he admits, “I think it’s a good study… but publishing something like that — might as well retire. I’d be finished.”

Following widespread media coverage, including criticism from Henry Ford, The Conversation, and Stat News, ICAN has released a response addressing their criticisms.

“We address these criticisms not because we must,” said ICAN in its published statement, “but because science demands debate. Every study should be challenged, discussed, and improved — without fear of professional reprisal.” Read the full response at https://www.aninconvenientstudy.com/criticisms

A Call for Scientific Transparency

An Inconvenient Study exposes the broader public health crisis that has seen rates of chronic illness in American schoolchildren soar from roughly 12% in 1986 to over 50% today. The film urges greater transparency, independent research, and true informed consent in public health policy.

“This isn’t about being pro or anti anything,” said Bigtree. “It’s about asking why our kids are so sick — and ensuring science remains open to honest inquiry.”

An Inconvenient Study is now available to stream globally, free of charge, at AnInconvenientStudy.com.
ICAN’s response to media criticisms can be found HERE.

MEDIA CONTACT:
Tracy Diaz
Tracy@thehighwire.com
(321) 345-6932
www.AnInconvenientStudy.com

Executive Producer Del Bigtree is available for interviews on this topic he sees as vital to the discussion around the childhood chronic disease epidemic in America.

Data Storage Corporation Postpones 2025 Third Quarter Business Update Conference Call
WALOVI’s International Cans Make Global Debut, Ushering in a New Era of Eastern Natural Plant Beverages
Four initiatives funded by the Olympic Refuge Foundation tackle inclusion and hate
Viettel Participates in Supplying High-Tech Defense Products to the Indian Market
Bahrain Sets New Global Benchmark with the World’s Largest Rooftop Solar Power Plant
TAGGED:andaward-winningchronicdebatediseasefilmglobalinconvenientnewssafetysparksstudyvaccine
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Business Sentiment Softens in Q4 Amid Global Uncertainty, while Domestic Orders Show Continued Resilience
News

Business Sentiment Softens in Q4 Amid Global Uncertainty, while Domestic Orders Show Continued Resilience

27/10/2025
Tamil Nadu Among India’s Most Insurance-Aware Markets: 100% Awareness, 70% Ready to Buy Life Insurance Soon
TriNetX Named Among the Top 25 Healthcare Software Companies of 2025
NYSE Content Advisory: Pre-Market update + S&P 500 trades within 1% of record
IBM Designated as a Critical Third-Party Provider Under EU DORA
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?